Common antibiotic part of a promising potential pancreatic cancer therapy
Despite surgical advances, pancreatic cancer continues to be one of the most deadly and difficult cancers to manage due to a lack of effective therapies. However, VCU Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) scientists in the lab of Paul B. Fisher, M.Ph., Ph.D., are hoping to change that with a novel combination of an experimental drug and a common antibiotic that has shown promising results in preclinical experiments.
Massey researcher leads team to improve data reporting of meningioma treatment outcomes nationwide
A new study led by VCU Massey Cancer Center physician-researcher Leland Rogers, M.D., found that clinical trials to treat the most common primary brain tumor, meningioma, lack uniform guidelines for how physicians should determine whether treatment is effective at shrinking the tumor. The study was published in the Journal of Neurosurgery.
Massey researcher leads task force to develop first guidelines for evaluating and treating children with thyroid cancer
VCU Massey Cancer Center researcher and Children’s Hospital of Richmond at VCU endocrinologist Gary Francis, M.D., Ph.D., recently led a task force commissioned by the American Thyroid Association (ATA) to develop a set of guidelines for evaluating and treating children with thyroid nodules and cancer. The newly issued guidelines are the first and only set of recommendations aimed at managing patients 18 years of age and younger with thyroid tumors and will provide the best practice standards for diagnosing and treating pediatric thyroid cancer.
Advanced viral gene therapy eradicates prostate cancer in preclinical experiments
Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies for these patients, researchers at VCU Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a unique approach that uses microscopic gas bubbles to deliver directly to the cancer a viral gene therapy in combination with an experimental drug that targets a specific gene driving the cancer’s growth.
Chat on colorectal cancer
In honor of Colorectal Cancer Awareness Month, ABC News National Health hosted a Twitter chat on the subject last week with everyone from clinicians to patients providing commentary. VCU Massey Cancer Center’s medical oncologist Khalid Matin, M.D., F.A.C.P., was able to answer questions and elaborate on the discussion topics posed by the moderator. An expert in gastrointestinal cancers, Matin is also the medical director of community oncology and clinical research affiliations at VCU Massey Cancer Center and an associate professor in the Division of Hematology, Oncology and Palliative Care in the Department of Internal Medicine at the VCU School of Medicine.